Universal HIV testing with linkage to treatment and prevention may be a promising approach to accelerate reductions in new infections in generalized epidemic settings,...
October 21st, 2020The HPTN084 study being conducted in six African countries holds out the promise of a bi-monthly injection for women as an empower new way to prevent HIV infection,...
Islatravir, the first of a new class of antiretrovirals, continued to demonstrate high potency and good tolerability at 96 weeks when combined with doravirine...HIV/AIDS
A novel immunoassay that measures urine tenofovir levels has high predictive utility and may adequately determine pre-exposure prophylaxis (PrEP) adherence and predict...HIV/AIDS
New data from Kaiser Permanente in San Francisco show that on-demand pre-exposure prophylaxis (PrEP) taken before and after sex – known as PrEP 2-1-1 – led to good...HIV/AIDS
A retrospective cohort study of gay and bisexual men attending sexual health clinics in Japan shows that taking HIV pre-exposure prophylaxis (PrEP) not only protects...HIV/AIDS
Unanswered questions about the safety of taking PrEP during pregnancy and breastfeeding should not be allowed to stand in the way of access to PrEP for women who need...Weekly Roundup
A report by Public Health England shows that HIV transmission in the UK has continued to fall, by as much as 71% in some categories. The report shows that, thanks to...HIV/AIDS
Pre-exposure prophylaxis (PrEP) – taking antiretroviral drugs to protect people from acquiring HIV infection – is revolutionising the prevention of HIV around the...Weekly Roundup
There is some bad news and worse news in the 2018 Sexually Transmitted Disease Surveillance Report, published earlier this month by the US Centres for Disease Control...
